HIV News and Research

RSS

Patients who receive automated telephone calls are more likely to have controlled hypertension

Patients who received automated telephone calls inviting them to get their blood pressure checked at a walk-in clinic were more likely to have controlled hypertension than patients who did not receive calls, according to a Kaiser Permanente study published today in the Journal of Clinical Hypertension.

17 Sep 2013

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

In the general population, current smoking prevalence is 18%. Persons living with HIV/AIDS smoke at a rate 2 to 3 times higher, up to almost 70% in some studies.

16 Sep 2013

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.

16 Sep 2013

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years.

16 Sep 2013

Research findings bring scientists one step closer to preventing HIV infections

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV’s entry.

13 Sep 2013

Study: Higher rates of acute hepatitis C virus clearance are seen in women

A study of patients infected with acute hepatitis C virus (HCV) infection found that women had higher rates of spontaneous viral clearance—undetectable levels of the virus without initiating drug therapy.

13 Sep 2013

Helper T cells important for AIDS vaccine development

A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

13 Sep 2013

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

A Kansas State University microbiologist has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people.

13 Sep 2013

Global Industry Analysis Report on Companion Diagnostics Market

New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

12 Sep 2013

New open access Journal of Clinical and Translational Endocrinology from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication - Journal of Clinical and Translational Endocrinology (JCTE).

12 Sep 2013

Becker's Hospital Review names Virginia Mason as one of 50 Greenest Hospitals in America

Virginia Mason has been named one of the 50 Greenest Hospitals in America for 2013 by Becker's Hospital Review, a leading health care publication.

12 Sep 2013

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

An HIV/AIDS vaccine candidate developed by researchers at Oregon Health & Science University appears to have the ability to completely clear an AIDS-causing virus from the body.

12 Sep 2013

Viewpoints: Hopes for single payer system remain; GOP's move to tie debt ceiling to health law is dangerous; subsidy fraud must be stopped

With the Oct. 1 rollout of a major facet of the Affordable Care Act on the horizon, you'll be hearing a lot about the glitches, loopholes and shortcomings of this most important restructuring of America's healthcare system in our lifetimes.

12 Sep 2013

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

Clinical Research Management, Inc. (ClinicalRM) – a full-service Contract Research Organization (CRO) providing services for basic and applied research, clinical trials, and regulatory support – announced today it was awarded a contract by the Department of Health and Human Services, National Institutes of Health, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID).

12 Sep 2013

Levels of certain fats in cerebral spinal fluid can predict patients with HIV, say scientists

Johns Hopkins scientists have found that levels of certain fats found in cerebral spinal fluid can predict which patients with HIV are more likely to become intellectually impaired.

12 Sep 2013

Phobias, anxiety are typical reasons why many decline to donate blood

As few as 3 percent of Americans eligible to donate blood do, and fear and anxiety are common reasons why many decline to give. U.S. hospitals are always in need of new donors; at Mayo Clinic, that need is heightened by concern about iron deficiency in frequent givers.

11 Sep 2013

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche and Inovio Pharmaceuticals, Inc. announced today that they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly-optimized, multi-antigen DNA immunotherapies targeting prostate cancer and hepatitis B.

10 Sep 2013

Brown, University of Cape Town partner to create next generation of HIV social science in South Africa

The public health schools at Brown University and the University of Cape Town have launched a new research and training partnership to create "the next generation of HIV social science in South Africa." The Eunice Kennedy Shriver National Institute of Child Health and Human Development is funding the collaboration with a new $1.9 million, five-year grant.

10 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

HIV News and Research

Patients who receive automated telephone calls are more likely to have controlled hypertension

Smoking-cessation in HIV-positive individuals: an interview with Dr Ellen R. Gritz, University of Texas MD Anderson Cancer Center

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

Research findings bring scientists one step closer to preventing HIV infections

Study: Higher rates of acute hepatitis C virus clearance are seen in women

Helper T cells important for AIDS vaccine development

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

Global Industry Analysis Report on Companion Diagnostics Market

New open access Journal of Clinical and Translational Endocrinology from Elsevier

Becker's Hospital Review names Virginia Mason as one of 50 Greenest Hospitals in America

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

Viewpoints: Hopes for single payer system remain; GOP's move to tie debt ceiling to health law is dangerous; subsidy fraud must be stopped

ClinicalRM signs contract with NIH to provide broad spectrum of services for STI CTG Program

Levels of certain fats in cerebral spinal fluid can predict patients with HIV, say scientists

Phobias, anxiety are typical reasons why many decline to donate blood

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Brown, University of Cape Town partner to create next generation of HIV social science in South Africa

Research roundup: The financial burden of hospital acquired infections

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News